Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 95.162M	--
--	2024/Q4	-- / 101.642M	--
Nov 11, 2024	2024/Q3	96.910M / 93.004M	--
Aug 6, 2024	2024/Q2	104.161M / 107.104M	--
May 7, 2024	2024/Q1	101.899M / 97.931M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 95.162M--

--2024/Q4-- / 101.642M--

Nov 11, 20242024/Q396.910M / 93.004M--

Aug 6, 20242024/Q2104.161M / 107.104M--

May 7, 20242024/Q1101.899M / 97.931M--

Unlock Free Earnings Estimates

Open Account

Nevro Earnings Reports

Nevro | 8-K: Nevro Announces Preliminary Fourth-Quarterand Full-Year 2024 Revenue Results

Jan 14 12:32 ET

Nevro | 8-K: Nevro Reports Third-Quarter 2024 Financial Results Reaffirms Full-Year 2024 Revenue Guidance and Raises Full-Year 2024 Adjusted EBITDA Guidance

Nov 14, 2024 16:19 ET

Nevro | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 09:34 ET

Nevro | 10-Q: Q2 2024 Earnings Report

Aug 6, 2024 16:14 ET

Trending Stocks

Symbol Mini Chart % Chg

Collegium Pharmaceutical